Evaxion Biotech A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $14.00 price objective on the stock. Separately, Lake Street Capital reduced their price target on shares of Evaxion Biotech A/S from $35.00 to $6.00 and set […]
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $14.00 price objective on the stock. Separately, Lake Street Capital reduced their price target on shares of Evaxion Biotech A/S from $35.00 to $6.00 and set […]
